1. Home
  2. RDHL vs MDJH Comparison

RDHL vs MDJH Comparison

Compare RDHL & MDJH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • MDJH
  • Stock Information
  • Founded
  • RDHL 2009
  • MDJH 2002
  • Country
  • RDHL Israel
  • MDJH United Kingdom
  • Employees
  • RDHL N/A
  • MDJH N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • MDJH Real Estate
  • Sector
  • RDHL Health Care
  • MDJH Finance
  • Exchange
  • RDHL Nasdaq
  • MDJH Nasdaq
  • Market Cap
  • RDHL 11.2M
  • MDJH 9.8M
  • IPO Year
  • RDHL N/A
  • MDJH 2019
  • Fundamental
  • Price
  • RDHL $7.15
  • MDJH $0.18
  • Analyst Decision
  • RDHL
  • MDJH
  • Analyst Count
  • RDHL 0
  • MDJH 0
  • Target Price
  • RDHL N/A
  • MDJH N/A
  • AVG Volume (30 Days)
  • RDHL 14.3K
  • MDJH 14.0M
  • Earning Date
  • RDHL 11-19-2024
  • MDJH 01-01-0001
  • Dividend Yield
  • RDHL N/A
  • MDJH N/A
  • EPS Growth
  • RDHL N/A
  • MDJH N/A
  • EPS
  • RDHL N/A
  • MDJH N/A
  • Revenue
  • RDHL $3,707,000.00
  • MDJH $114,849.00
  • Revenue This Year
  • RDHL $224.90
  • MDJH N/A
  • Revenue Next Year
  • RDHL $82.69
  • MDJH N/A
  • P/E Ratio
  • RDHL N/A
  • MDJH N/A
  • Revenue Growth
  • RDHL N/A
  • MDJH 289.97
  • 52 Week Low
  • RDHL $6.80
  • MDJH $0.14
  • 52 Week High
  • RDHL $82.00
  • MDJH $1.90
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 29.71
  • MDJH 27.57
  • Support Level
  • RDHL $7.98
  • MDJH $0.16
  • Resistance Level
  • RDHL $7.36
  • MDJH $0.33
  • Average True Range (ATR)
  • RDHL 0.37
  • MDJH 0.04
  • MACD
  • RDHL -0.12
  • MDJH -0.00
  • Stochastic Oscillator
  • RDHL 0.00
  • MDJH 6.24

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About MDJH MDJM LTD

MDJM Ltd is a real estate service company. The company provides real estate agency services to real estate developer clients, as well as real estate consulting services and independent training services on an as-needed basis. It offers consulting, marketing planning, advertising services, and sales strategies to real estate clients. The company income is derived from commission-based services and minimal consulting and other services. The company has two operating segments; the real estate agent services segment and the hospitality business segment. It derives a majority of its revenue from the People's Republic of China.

Share on Social Networks: